Split History
ETFs Holding ASMB »    ASMB Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Assembly Biosciences is a clinical stage biotechnology company. Co. is focusing on two platform programs: an oral therapeutics for the treatment of hepatitis B virus (HBV) infection and a class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. Co.'s HBV-cure program, with its primary product candidate, ABI-H0731, is aimed at increasing the low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. The primary product candidate from Co.'s microbiome platform, ABI-M101, is in development for the treatment of clostridium difficile infections. According to our ASMB split history records, Assembly Biosciences has had 1 split.
ASMB split history picture
Assembly Biosciences (ASMB) has 1 split in our ASMB split history database. The split for ASMB took place on July 14, 2014. This was a 1 for 5 reverse split, meaning for each 5 shares of ASMB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as Assembly Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ASMB split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Assembly Biosciences shares, starting with a $10,000 purchase of ASMB, presented on a split-history-adjusted basis factoring in the complete ASMB split history. ASMB split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/17/2010
End date: 05/24/2017
Start price/share: $31.50
End price/share: $25.35
Dividends collected/share: $0.00
Total return: -19.52%
Average Annual Total Return: -3.32%
Starting investment: $10,000.00
Ending investment: $8,046.97
Years: 6.44
Date Ratio
07/14/20141 for 5
ASMB is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ASTM Split History
ATE Split History
ATEC Split History
ATOS Split History
ATRC Split History
ATRI Split History
AVXL Split History
AZN Split History
BAX Split History
BCR Split History

Xerox Corporation (XRX)
Waste Connections, Inc. (WCN)
Spark Energy, Inc. (SPKE)
MagneGas Corporation (MNGA)
Frontier Communications Corporation (FTR)
NeuroMetrix, Inc. (NURO)
Pain Therapeutics, Inc. (PTIE)
Rex Energy Corporation (REXX)
Rexahn Pharmaceuticals, Inc. (RNN)
Dataram Corporation (DRAM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ASMB Insider Buying

ASMB Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.